Sélectionnez l'édition
Pays
Objectif principal
Maladie
Type d'Organisation
Partie prenante
Qualité
Third Edition BOGP (10)
Advocacy (policy advocacy, lobbying)
Foundation (0)
Pharmaceutical companies or industry (incl. Medical device and biotech companies)
Transparency in communication and documentation
Clinical study phase II